Medtronic plc Stock
€84.20
Your prediction
Medtronic plc Stock
Pros and Cons of Medtronic plc in the next few years
Pros
Cons
Performance of Medtronic plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Medtronic plc | 0.260% | -1.034% | -3.207% | 9.138% | 9.280% | 15.755% | -11.545% |
| Dexcom Inc. | 0.850% | -1.122% | 8.838% | -22.877% | -25.298% | -46.702% | -22.924% |
| Henry Schein Inc. | 0.670% | 0.767% | 6.864% | -1.203% | -1.529% | -13.644% | 16.946% |
| Zimmer Holdings | -1.190% | -2.410% | -1.907% | -25.390% | -25.096% | -35.779% | -38.597% |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Upon first glance at Medtronic's financials, the company appears to be a strong player in the Healthcare Equipment & Supplies sector. Over the years, Medtronic has demonstrated relatively stable financial performance, which is a desirable attribute for a healthcare company. However, more in-depth analysis is needed to better understand the pros and cons of its financial situation.
Revenue Growth: Medtronic's total revenue has experienced consistent growth over the last three years as seen in the yearly income statements. In 2020, the company recorded total revenue of $28.913 billion which increased to $30.117 billion in 2021, and further to $31.686 billion in 2022.
Increasing Gross Profit: Medtronic has seen a rise in its gross profit, from $19.489 billion in 2020 to $19.634 billion in 2021, and eventually $21.541 billion in 2022. This implies that the company is becoming more efficient in its manufacturing and supply chain activities, which is a good sign for potential investors.
Comments
News
3 Top Dividend Stocks I Plan to Buy Hand Over Fist in 2026
Investing in dividend stocks is a proven way to grow wealth. Over the last 50 years, dividend stocks have delivered more than double the average annual total return compared to non-dividend payers,
This Dividend Stock Just Hit a Major Milestone. Time to Buy?
Medtronic (NYSE: MDT), a medical device specialist, has performed well this year. That's despite the threat of tariffs, which are having a material impact on its earnings. However, its financial
Forget Medtronic, Buy This Healthcare Stock Instead
There are compelling reasons for some investors to consider investing in Medtronic (NYSE: MDT), depending on their goals and risk tolerance. It is a well-established healthcare leader that generates